GrantQuick

Opioid Prevention Grants

86 active federal grants matching "opioid". Updated daily.

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-CA-28-013

Closes Feb 9, 2027

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-RM-27-007

Closes Nov 23, 2026

NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)

HHS-NIH11 · RFA-AR-28-001

Closes Mar 1, 2029

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-RM-27-016

Closes Nov 23, 2026

Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-RM-27-025

Closes Nov 23, 2026

Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-HL-27-010

Closes Oct 13, 2028

Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-DA-28-013

Closes Feb 8, 2027

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

HHS-NIH11 · RFA-HG-27-010

Closes Dec 14, 2026

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-HG-27-007

Closes Dec 14, 2026

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-HG-27-009

Closes Dec 14, 2026

IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)

HHS-NIH11 · RFA-HG-27-008

Closes Dec 14, 2026

OJJDP FY 2026 Opioid Affected Youth Initiative

USDOJ-OJP-OJJDP · O-OJJDP-2026-172748

Closes Nov 16, 2026

OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use

USDOJ-OJP-OJJDP · O-OJJDP-2026-172743

Closes Nov 16, 2026

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

HHS-NIH11 · RFA-RM-27-024

Closes Nov 10, 2026

HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)

HHS-NIH11 · RFA-DA-28-012

Closes Jan 26, 2027

HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)

HHS-NIH11 · RFA-DA-28-011

Closes Jan 26, 2027

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

HHS-NIH11 · RFA-AI-27-018

Closes Jun 20, 2029

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-AI-28-031

Closes May 28, 2027

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-NS-28-010

Closes Feb 8, 2029

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

HHS-NIH11 · RFA-MH-27-125

Closes Oct 28, 2027

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

HHS-NIH11 · PAR-27-045

Closes Oct 30, 2026

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

HHS-NIH11 · PAR-28-072

Closes Nov 16, 2029

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

HHS-NIH11 · PAR-28-057

Closes May 25, 2027

BJA FY 2026 Tribal Justice Training and Technical Assistance Program

USDOJ-OJP-BJA · O-BJA-2026-172727

Closes Oct 21, 2026

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

HHS-NIH11 · PAR-28-056

Closes Nov 5, 2029

About Opioid Prevention Grants

The federal government funds opioid programs through competitive grants posted on Grants.gov. Eligible applicants typically include 501(c)(3) nonprofits, state/local governments, tribal organizations, and educational institutions. Applications usually require a project narrative, budget justification, and evidence of organizational capacity. New opportunities post year-round with 30-60 day application windows.